Cycle Pharmaceuticals is a pioneering rare disease pharmaceutical company reimagining how drugs can benefit patients, to make their lives easier and improve their quality of life at every stage.
Cycle focuses on improving orphan drugs by optimizing formulations and applying new drug delivery technologies. This enables Cycle to provide patients and their caregivers with greater freedom and choice.
With Headquarters in Cambridge (UK) and offices in Boston, Mass. (US), Cycle has developed unique partnerships with renowned universities, technology companies and distributors around the world.